BNET Industries

Genmab A/S

GEN is in the Business Services Industry

Last Fiscal Year Sales:$41.8M
  • Public
  • DK
Dow Jones Description

Genmab is dedicated to creating and developing human antibodies to help people suffering from life-threatening and debilitating diseases. Our goal is to serve patients in need of new types of therapy and to build a business that maximizes value for patients and shareholders.

President & CEO
Lisa N. Drakeman
Number of Employees 555
Contact Information

Toldbogade 33

Copenhagen

www.genmab.com

(45) 7020 2728

NAICS Code Research and Development in the Social Sciences and Humanities: 541720

Recent Events

  • Genmab Announces Results for the Nine Months Period of 2009

    11/10/09 - Financial Announcement - View Story

  • Ofatumumab Misses NHL Mark; Genmab Shares Take a Tumble

    8/18/09 - Financial Announcement - View Story

  • Genmab Announces Lift of Zalutumumab Partial Clinical Hold

    7/16/09 - Bond / Stock Rating - View Story

  • Genmab Announces Lift of Zalutumumab Partial Clinical Hold

    7/16/09 - Bond / Stock Rating - View Story

News & Analysis

genmab a/s - All News and Analysis

  • S&P Equity hikes Danish Genmab target to DKK298

    - 2009-08-13

    NORDIC BUSINESS REPORT-13 August 2009-S&P Equity hikes Danish Genmab target to DKK298C1994-2009 M2 COMMUNICATIONS http://www.m2.com 13 August 2009- Standard & Poor's Equity Research (S&P) raised the share price target on Danish biotech company Genmab A/S (CPH: GEN) to DKK298 from DKK258 and maintained the "buy" recommendation. ...

    Tags: Genmab A/S

  • Danish Genmab announces good phase II data for Arzerra in CLL

    - 2009-08-12

    NORDIC BUSINESS REPORT-12 August 2009-Danish Genmab announces good phase II data for Arzerra in CLLC1994-2009 M2 COMMUNICATIONS http://www.m2.com 12 August 2009 - Danish biotech company Genmab A/S (CPH: GEN) announced on Tuesday positive top-line results from a phase II study with its drug Arzerra to treat chroniclymphocytic...

    Tags: Genmab A/S

  • ING stops monitoring Danish Vestas, Genmab

    - 2009-08-03

    NORDIC BUSINESS REPORT-3 August 2009-ING stops monitoring Danish Vestas, GenmabC1994-2009 M2 COMMUNICATIONS http://www.m2.com 3 August 2009 - ING has discontinued its coverage of a number of European stocks, among them Danish biotech company Genmab A/S (CPH: GEN) and wind-turbine maker Vestas Wind Systems A/S (CPH: VWS). ...

    Tags: Genmab A/S

  • Genmab announces positive phase III data for RA drug

    - 2009-07-30

    NORDIC BUSINESS REPORT-30 July 2009-Genmab announces positive phase III data for RA drugC1994-2009 M2 COMMUNICATIONS http://www.m2.com 30 July 2009 - Danish biotech company Genmab A/S (CPH: GEN) said Wednesday it had obtained positive preliminary results from a phase III study with drug candidate ofatumumab in rheumatoid arthritis...

    Tags: Genmab A/S

  • Amagerbanken makes profit-taking move in Genmab

    - 2009-07-28

    NORDIC BUSINESS REPORT-28 July 2009-Amagerbanken makes profit-taking move in GenmabC1994-2009 M2 COMMUNICATIONS http://www.m2.com 28 July 2009 - Amagerbanken said it is taking profits today from the stock in Danish biotech company Genmab A/S (CPH: GEN), which it has rated at "buy" with a certain cautiousness. However,...

    Tags: Amagerbanken A/S, Genmab A/S

Decision Makers

Name (plus bio) Position
Lisa N. Drakeman President & CEO
Bo Kruse CFO & Vice President
Claus Juan Moller COO & Executive Vice President
Claus Juan Moller-San Pedro COO & Executive Vice President
David Eatwell Chief Financial Officer
Jan G.J. Van De Winkel Chief Scientific Officer
Annarie Lyles Senior Vice President & Head, Business Dev
Matthew Dean Vice President, Sales & Marketing
Rachel C. Gravesen Vice President, Public & IR
Helle Husted Senior Director, IR
Irwin Lerner Director

Board of Directors

Name (plus bio) Position
Anders Gersel Pedersen Deputy Chairman
Michael B. Widmer Chairman
Burton G. Malkiel Board of Directors
Ernst H. Schweizer Board of Directors
Hans Henrik Munch-Jensen Board of Directors
Karsten Havkrog Pedersen Board of Directors

Organization Position Status
Genmab A/S President & CEO Current
Genmab A/S Board of Directors Current

Organization Position Status
Genmab A/S CFO & Vice President Current

Organization Position Status
Genmab A/S COO & Executive Vice President Current

Organization Position Status
Genmab A/S COO & Executive Vice President Current

Organization Position Status
Genmab A/S Chief Financial Officer Current
Catalent Pharma Solutions, Inc. Senior Vice President & Chief Financial Officer Current

Organization Position Status
Genmab A/S Chief Scientific Officer Current
Biotech Turnaround Fund Bv Current
Genmab A/S Executive Vice President Former
Medarex, Inc. Vice President Former
Medarex, Inc. Scientific Director of Medarex Former

Organization Position Status
Genmab A/S Senior Vice President & Head, Business Dev Current
Genmab A/S Head, Business Development Former

Organization Position Status
Genmab A/S Vice President, Sales & Marketing Current

Organization Position Status
Genmab A/S Vice President, Public & IR Current

Organization Position Status
Genmab A/S Senior Director, IR Current

Organization Position Status
Genmab A/S Deputy Chairman Current
Genmab, Inc. Board of Directors Current
Topotarget Sa Board of Directors Current
Copenhagen Business School B.Sc. In Business Administration Former
University of Copenhagen Degree Former
Copenhagen Business School Degree Former

Organization Position Status
Genmab A/S Chairman Current

Organization Position Status
Genmab A/S Board of Directors Current

Organization Position Status
Genmab A/S Board of Directors Current

Organization Position Status
Genmab A/S Board of Directors Current

Organization Position Status
Hoffmann-La Roche Inc. Chief Executive Officer Current
Medarex, Inc. Chairman Current
Covance, Inc. Director Current
Centralized Ecg Director Current
Cardiac Safety Director Current
Sternberger Monoclonals Inc.(Smi) Director Current
Nektar Therapeutics Director Current
Six Sigma Companies Director Current
Genmab A/S Director Current
Panacos Pharmaceuticals, Inc. Board of Directors Current
Roche Chief Executive Officer Former
Medarex, Inc. CEO Former
Reliant Pharmaceuticals, Inc. Chief Executive Officer Former
Roche President Former
Hoffmann-La Roche Inc. President Former
Medarex, Inc. Interim President Former
Hoffmann-La Roche Inc. Chairman of the Board of Directors Former
Humana Inc. Board of Directors Former
Medarex, Inc. Director Former
Rutgers University MBA Degrees Former
Rutgers University B.S. Former

Organization Position Status
Genmab A/S Board of Directors Current

Executive News

  • Genmab Announces Positive Top-Line Results for Arzerra in Front Line NHL

    Pharma Live - 8/26/09 - View Story

  • Genmab Announces Positive Top-Line Results for Arzerra(tm) in Front Line NHL

    Reuters - 8/26/09 - View Story

  • Ofatumumab Misses NHL Mark; Genmab Shares Take a Tumble

    BioWorld - 8/18/09 - View Story

  • Genmab Announces Preliminary Top-Line Results for Arzerra in Front Line CLL

    Pharma Live - 8/15/09 - View Story

  • Genmab Announces Preliminary Top-Line Results for Arzerra(TM) in Front Line CLL

    Reuters - 8/11/09 - View Story

advertisement
Glass Door

Business Services Industry Companies

Company Employer Rating
PayPal 3.1
FedEx 3.7
Accenture 3.4
Gartner 3.3
UPS 3.1
IndustryTop Rated
advertisement